Literature DB >> 33327445

Obstruction of the Hepatic Venous Flow Caused by Intravenous Leiomyomatosis.

Sin-Youl Park1, In Hwan Yeo2, Yun Jeong Kim2, Jong Kun Kim2.   

Abstract

Budd-Chiari syndrome (BCS) is a rare intrahepatic vascular disease that is characterized by a hepatic venous outflow obstruction. Intravenous leiomyomatosis (ILs) is a rare complication of a myoma. Here, we report a case of BCS that was caused by intracaval ILs. A woman presented to the emergency department (ED) with abdominal distension that had gradually progressed over a period of 3 years. Bedside ultrasonography and contrast-enhanced computed tomography (CECT) showed a large ascites and pelvic mass. The mass continued to the inferior vena cava and the right atrium. The intracaval mass was obstructing the left and middle hepatic veins. We established a tentative diagnosis of BCS caused by intracaval ILs and attempted surgical resection. Complete resection of the intracaval mass failed because of adhesion; however, she was discharged from the hospital without any postoperative complications. After 3 months, a pelvic ultrasonography showed a recurrence of a 4 × 3 cm pelvic mass. The mass size increased to 6 cm after 30 months. ILs can cause secondary BCS and can lead to life-threatening conditions. Owing to its extreme rarity, early detection in the ED is challenging. Bedside ultrasonography and CECT can enable the early recognition of BCS by ILs.

Entities:  

Keywords:  Budd–Chiari syndrome; Inferior vena cava; leiomyoma; leiomyomatosis; ultrasonography

Mesh:

Year:  2020        PMID: 33327445      PMCID: PMC7764919          DOI: 10.3390/medicina56120696

Source DB:  PubMed          Journal:  Medicina (Kaunas)        ISSN: 1010-660X            Impact factor:   2.430


  29 in total

1.  Intravenous leiomyomatosis extending to the heart.

Authors:  G M Khayata; S Thwaini; S G Aswad
Journal:  Int J Gynaecol Obstet       Date:  2003-01       Impact factor: 3.561

2.  Intravenous leiomyomatosis of the uterus: a GnRH agonist utilisation before surgery.

Authors:  P J Barjot; N Refahi; P Berthet; V D Delautre
Journal:  J Obstet Gynaecol       Date:  1998-09       Impact factor: 1.246

3.  Clinicopathological forms and prognostic index in Budd-Chiari syndrome.

Authors:  Philippe Langlet; Sylvie Escolano; Dominique Valla; Delphine Coste-Zeitoun; Cecile Denie; Alain Mallet; Victor-Georges Levy; Dominique Franco; Jean-Pierre Vinel; Jacques Belghiti; Didier Lebrec; Jean-Marie Hay; Guy Zeitoun
Journal:  J Hepatol       Date:  2003-10       Impact factor: 25.083

Review 4.  Clinical update of smooth muscle tumors of the uterus.

Authors:  Leigh A Solomon; Veronica L Schimp; Rouba Ali-Fehmi; Michael P Diamond; Adnan R Munkarah
Journal:  J Minim Invasive Gynecol       Date:  2005 Sep-Oct       Impact factor: 4.137

5.  Estrogen and progesterone expression of vessel walls with intravascular leiomyomatosis; discussion of histogenesis.

Authors:  G Kir; M Kir; A Gurbuz; A Karateke; F Aker
Journal:  Eur J Gynaecol Oncol       Date:  2004       Impact factor: 0.196

6.  Smooth muscle tumors of the inferior vena cava and right heart.

Authors:  W C Peh; D L Cheung; H Ngan
Journal:  Clin Imaging       Date:  1993 Apr-Jun       Impact factor: 1.605

7.  The changing scene of hepatic vein thrombosis: recognition of asymptomatic cases.

Authors:  A Hadengue; M Poliquin; V Vilgrain; J Belghiti; C Degott; S Erlinger; J P Benhamou
Journal:  Gastroenterology       Date:  1994-04       Impact factor: 22.682

8.  Innovative oral treatments of uterine leiomyoma.

Authors:  Mohamed Sabry; Ayman Al-Hendy
Journal:  Obstet Gynecol Int       Date:  2012-02-16

9.  Intravenous leiomyomatosis: an unusual intermediate between benign and malignant uterine smooth muscle tumors.

Authors:  Zehra Ordulu; Marisa R Nucci; Paola Dal Cin; Monica L Hollowell; Christopher N Otis; Jason L Hornick; Peter J Park; Tae-Min Kim; Bradley J Quade; Cynthia C Morton
Journal:  Mod Pathol       Date:  2016-02-19       Impact factor: 7.842

Review 10.  Intravenous leiomyomatosis: Case series and review of the literature.

Authors:  Na Liu; Yan Long; Yun Liu
Journal:  J Int Med Res       Date:  2020-01       Impact factor: 1.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.